RRP9 and neuroblastoma: In two public NB datasets (GSE62564 and GSE45547), BYSL (P = 1.0 × 10−17 and 1.8 × 10−9), NOP58 (P = 3.4 × 10−13 and 2.9 × 10−8) or RRP9 (P = 4.6 × 10−14 and 2.0 × 10−13) expression was substantially linked to worse survival of patients (Figure S11).